Events

Healthcare remains top-of-mind for antitrust enforcers in 2024. As the year turned, the federal antitrust agencies finalized new Merger Guidelines and put theories into practice with new enforcement actions. In this webinar we will discuss how these trends will continue to play out throughout 2024 in agency enforcement actions in mergers of healthcare and pharmaceutical companies, employment-related agreements, and pharma company mergers and conduct.

Learning Objectives: 

• Understand the new theories that the agencies are pursuing in their review of healthcare transactions, and the potential impact on dealmaking.
  
• Learn the federal and state agencies' enforcement agenda in relation to employment-related issues, such as non-competes and no-poach agreements.
• Discuss recent antitrust enforcement actions in the pharmaceutical sphere.

Speakers: 

• John Carroll, Partner, Sheppard Mullin
• Lisl Dunlop, Partner, Axinn
• Rosa Morales, Counsel, Crowell & Moring LLP
• Rahul Rao, Deputy Director of the Bureau of Competition, Federal Trade Commission

Click here to register.